Specialty Medicines - Neurology

Actavis Indonesia is committed to delivering medicines to meet the needs of patients and families affected by disorders of the Central Nervous System (CNS). Actavis provides products to treat patients with neurological and neurodegenerative disorders, pain, and musculoskeletal disorders, in countries around the world. Actavis is also developing innovative solutions in headache and migraine.

Pain Management

Actavis offers effective solutions as non-opioid therapeutic pain management for the relief of acute or chronic treatment of pain.

ALPENTIN (Gabapentin) for neuropathic pain management with globally selective raw material, local production.

DEFLAMAT CR (Sodium Diclofenac with Controlled Release Technology) for Nociceptive pain management with global raw material & production to ensure global fit standard of its quality throughout the years.

ACNOPAIN (Etoricoxib) formulated with enteric coated tablet to ensure the bioavailability, locally produced with COPB & EU GMP standard Quality, and Bioequivalent with its Originator. 

Neurobehaviour Management

NEMDATINE (Memantine HCl) as global brand from Actavis Iceland with EU GMP standard quality for Alzheimer Dementia with behavioral & psychological challenge to enhance the quality of life and to delay the progression of the disease. Movement Disorders Management

Movement Disorders Management

AZILECT (Rasagiline mesylate) is a monoamine oxidase type B (MAO-B) inhibitor Rasagiline is used to treat symptoms of Parkinson's disease both alone and in combination with other drugs. It has shown efficacy in both early and advanced Parkinson's

Epilepsy Management

ANTILEP (Levetiracetam) is an anticonvulsant medication used to treat various types of seizure associated with epilepsy. Antilep available in 250 mg and 500 mg dosage strengths, providing effective treatment options for managing partial-onset seizure, myoclonic seizures, and generalized tonic-clonic seizures in patients with epilepsy.